LeMaitre Vascular マネジメント

マネジメント基準チェック /44

LeMaitre Vascularの CEO はGeorge LeMaitreで、 Jun1992年に任命され、の在任期間は 32.42年です。の年間総報酬は$ 2.22Mで、 26.7%給与と73.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の8.32%を直接所有しており、その価値は€ 191.29M 。経営陣と取締役会の平均在任期間はそれぞれ14.6年と19年です。

主要情報

George LeMaitre

最高経営責任者

US$2.2m

報酬総額

CEO給与比率	26.7%
CEO在任期間	32.4yrs
CEOの所有権	8.3%
経営陣の平均在職期間	14.6yrs
取締役会の平均在任期間	19yrs

経営陣の近況

Recent updates

CEO報酬分析

LeMaitre Vascular の収益と比較して、George LeMaitre の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$41m
Jun 30 2024	n/a	n/a	US$38m
Mar 31 2024	n/a	n/a	US$34m
Dec 31 2023	US$2m	US$593k	US$30m
Sep 30 2023	n/a	n/a	US$27m
Jun 30 2023	n/a	n/a	US$25m
Mar 31 2023	n/a	n/a	US$21m
Dec 31 2022	US$2m	US$568k	US$21m
Sep 30 2022	n/a	n/a	US$21m
Jun 30 2022	n/a	n/a	US$22m
Mar 31 2022	n/a	n/a	US$27m
Dec 31 2021	US$2m	US$473k	US$27m
Sep 30 2021	n/a	n/a	US$28m
Jun 30 2021	n/a	n/a	US$29m
Mar 31 2021	n/a	n/a	US$24m
Dec 31 2020	US$1m	US$311k	US$21m
Sep 30 2020	n/a	n/a	US$19m
Jun 30 2020	n/a	n/a	US$16m
Mar 31 2020	n/a	n/a	US$18m
Dec 31 2019	US$1m	US$438k	US$18m
Sep 30 2019	n/a	n/a	US$19m
Jun 30 2019	n/a	n/a	US$18m
Mar 31 2019	n/a	n/a	US$23m
Dec 31 2018	US$1m	US$438k	US$23m
Sep 30 2018	n/a	n/a	US$21m
Jun 30 2018	n/a	n/a	US$22m
Mar 31 2018	n/a	n/a	US$18m
Dec 31 2017	US$889k	US$162k	US$17m

報酬と市場: Georgeの総報酬 ($USD 2.22M ) は、 German市場 ($USD 1.92M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Georgeの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

George LeMaitre (59 yo)

32.4yrs

在職期間

US$2,220,797

報酬

Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
George LeMaitre	Chairman & CEO	32.4yrs	US$2.22m	8.32% € 191.3m
David Roberts	President & Director	17.3yrs	US$1.13m	0.063% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	17.3yrs	US$1.07m	0.039% € 900.5k
Trent Kamke	Senior Vice President of Operations	19.8yrs	US$670.38k	0.0071% € 162.5k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	41.8yrs	US$138.40k	データなし
Kimberly Cieslak	Vice President of Marketing	21.8yrs	データなし	データなし
Daniel Mumford	Senior Director of Human Resources	4.8yrs	データなし	データなし
Jonathan Ngau	Senior Vice President of Information Technology	less than a year	データなし	データなし
Maik Helmers	Senior Vice President of Sales – Central Europe	less than a year	データなし	データなし
Ryan Connelly	Senior Vice President of Advanced Manufacturing Engineering	1.8yrs	データなし	データなし
Andrew Hodgkinson	Senior Vice President of Clinical	11.8yrs	データなし	データなし
Stephane Maier	Senior Vice President of EMEA Operations	4.1yrs	データなし	データなし

14.6yrs

平均在職期間

50.5yo

平均年齢

経験豊富な経営陣: LHUの経営陣は経験豊富で経験豊富です（平均在職期間は14.6年）。

取締役

名称	ポジション	在職期間	報酬	所有権
George LeMaitre	Chairman & CEO	32.4yrs	US$2.22m	8.32% € 191.3m
David Roberts	President & Director	23.5yrs	US$1.13m	0.063% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	8.1yrs	US$1.07m	0.039% € 900.5k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	no data	US$138.40k	データなし
Lawrence Jasinski	Independent Director	21.8yrs	US$153.50k	0.017% € 379.4k
Thomas Naslund	Member of Scientific Advisory Board	no data	データなし	データなし
Steven Kagan	Member of Scientific Advisory Board	no data	データなし	データなし
Herbert Dardik	Member of Scientific Advisory Board	no data	データなし	データなし
Alan Dardik	Member of Scientific Advisory Board	no data	データなし	データなし
William Jordan	Member of Scientific Advisory Board	no data	データなし	データなし
John O'Connor	Independent Director	16.2yrs	US$163.00k	0.21% € 4.9m
Bridget Ross	Independent Director	4.6yrs	US$144.50k	0.0052% € 120.4k

19.0yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: LHUの取締役会は経験豊富で経験豊富です ( 19年の平均在任期間)。

LeMaitre Vascular マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

President & Director recently sold €353k worth of stock

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Chairman & CEO recently sold €2.6m worth of stock

Chairman & CEO recently sold €411k worth of stock

President & Director recently sold €505k worth of stock

Recent updates

Third quarter dividend of US$0.16 announced

Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024

Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023)

LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024

Second quarter 2024 earnings released: EPS: US$0.53 (vs US$0.36 in 2Q 2023)

LeMaitre Vascular, Inc. to Report Q2, 2024 Results on Aug 01, 2024

First quarter dividend of US$0.16 announced

President & Director recently sold €353k worth of stock

First quarter 2024 earnings released: EPS: US$0.44 (vs US$0.27 in 1Q 2023)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024

LeMaitre Vascular, Inc. to Report Q1, 2024 Results on May 02, 2024

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Upcoming dividend of US$0.16 per share

Fourth quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Full year 2023 earnings released: EPS: US$1.36 (vs US$0.94 in FY 2022)

LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces an Equity Buyback for $50 million worth of its shares.

LeMaitre Vascular, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Chairman & CEO recently sold €2.6m worth of stock

Upcoming dividend of US$0.14 per share at 1.1% yield

Third quarter 2023 earnings released: EPS: US$0.34 (vs US$0.25 in 3Q 2022)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on November 30, 2023

Now 20% undervalued after recent price drop

LeMaitre Vascular, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Investor sentiment deteriorates as stock falls 19%

Upcoming dividend of US$0.14 per share at 1.0% yield

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023, Fourth Quarter and Full Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$0.36 (vs US$0.16 in 2Q 2022)

LeMaitre Vascular, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Chairman & CEO recently sold €411k worth of stock

Upcoming dividend of US$0.14 per share at 0.8% yield

President & Director recently sold €505k worth of stock

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2023

First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2022)

Insufficient new directors

Senior Vice President of Operations recently sold €308k worth of stock

Full year 2022 earnings released: EPS: US$0.94 (vs US$1.27 in FY 2021)

LeMaitre Vascular, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Upcoming dividend of US$0.13 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.30 in 3Q 2021)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q3, 2022 Results on Oct 27, 2022

Lemaitre Vascular, Inc. Appoints Martha Shadan as Director

Upcoming dividend of US$0.13 per share

CFO, Treasurer recently sold €146k worth of stock

CFO, Treasurer recently sold €146k worth of stock

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.40 in 2Q 2021)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 8, 2022

LeMaitre Vascular, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Now 21% undervalued

First quarter 2022 earnings released: EPS: US$0.28 (vs US$0.29 in 1Q 2021)

LeMaitre Vascular, Inc. to Report Q1, 2022 Results on Apr 28, 2022

LeMaitre Vascular, Inc., Annual General Meeting, Jun 01, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.11 per share

Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.37 in 3Q 2020)

Upcoming dividend of US$0.11 per share

Second quarter 2021 earnings released: EPS US$0.40 (vs US$0.17 in 2Q 2020)

LeMaitre Vascular, Inc. has completed a Follow-on Equity Offering in the amount of $54.5 million.

LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Value Index

Upcoming dividend of US$0.11 per share

マネジメント基準チェック /44